Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

April 1, 2018

COMPLEMENTARY AND ALTERNATIVE MEDICINE

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
There is so much to print about this subject, that I find it impossible to figure-out where I want to…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

April 1, 2018

Potentially Harmful Supplements for People with MS

  • Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)
    /
this note had been published many years ago. We simply want to remind all: Periodically, I think it is helpful…
Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

March 31, 2018

Why Clinical Trials Matter – You play an essential role

  • MS Research Study and Reports
    /
  • TOOLS
    /
 https://www.guidetoclinicaltrials.com/why-clinical-trials-matter Before a potential new medicine can be used to help treat patients, it must go through a series of…
MS Research Study and Reports

March 29, 2018

• GeNeuro-Servier Antibody Limits RRMS Patients’ Brain Shrinkage, Phase 2b Trial Shows

  • MS Research Study and Reports
    /
March 29, 2018 The laboratory-generated antibody GNbAC1 continued to limit brain shrinkage a year after relapsing-remitting multiple sclerosis patients began receiving it, its…
MS Research Study and Reports

March 25, 2018

Predicting Episodic Memory Loss in Patients with MS

  • Multiple Sclerosis (MS) Symptoms
    /
Mult Scler; ePub 2018 Mar 7; Koenig, et al March 20, 2018 Functional activation may be useful as a predictive…
Multiple Sclerosis (MS) Symptoms

March 25, 2018

Sun Exposure Associated with Lower MS Risk

  • Multiple Sclerosis
    /
Neurology; ePub 2018 Mar 7; Tremlett, et al March 20, 2018 Living in high ambient UV-B areas during childhood and…
Multiple Sclerosis

March 24, 2018

Phase III data in The Lancet show Novartis siponimod significantly improves outcomes in patients with Secondary Progressive MS (SPMS)

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
Mar 23, 2018 EXPAND shows oral siponimod (BAF312) is the first potential therapy to meaningfully delay disability progression in typical…
MS Drug Therapies

March 23, 2018

Lesion accumulation is predictive of long-term cognitive decline in multiple sclerosis

  • Additional MS resource sites
    /
  • MS Research Study and Reports
    /
OBJECTIVE: To investigate the long-term progression of cognitive dysfunction and its neuroanatomical correlates and predictors in multiple sclerosis (MS). To…
Additional MS resource sites

March 18, 2018

VIDEO: Multiple Sclerosis Treatment Algorithm: Avoiding Sins of Our Fathers!

  • Boster's MS Corner
    /
  • MS Educational Programs
    /
  • Multiple Sclerosis Videos
    /
Why do we insist on using an “escalation model” in treating MS? By escalation model, I’m referring to the common…
Boster's MS Corner

March 17, 2018

Multiple Sclerosis and Depression

  • Multiple Sclerosis (MS) Symptoms
    /
When you’re managing the symptoms of multiple sclerosis (MS), it’s natural that you might find there are times you feel…
Multiple Sclerosis (MS) Symptoms

Categories

Latest Blog Posts